SGHT(Sight Sciences, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $48.96M | $71.33M | $81.06M | $79.87M | $77.36M |
| 毛利润 | $40.35M | $58.97M | $69.17M | $68.28M | $66.67M |
| 营业利润 | −$51.48M | −$83.95M | −$57.27M | −$50.53M | −$37.10M |
| 净利润 | −$62.96M | −$86.24M | −$55.55M | −$51.51M | −$38.43M |
| 经营现金流 | −$52.54M | −$75.97M | −$47.18M | −$22.35M | −$29.69M |
| 自由现金流 | −$53.35M | −$76.94M | −$47.98M | −$22.74M | −$29.92M |
| 摊薄每股收益 | $-2.36 | $-1.80 | $-1.14 | $-1.03 | $-0.74 |